📣 VC round data is live. Check it out!
- Public Comps
- InnovAge
InnovAge Valuation Multiples
Discover revenue and EBITDA valuation multiples for InnovAge and similar public comparables like Omada Health, Ship Healthcare Holdings, Summerset Group Holdings, Enhabit and more.
InnovAge Overview
About InnovAge
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.
Founded
2015
HQ

Employees
2.4K
Website
Sectors
Financials (LTM)
EV
$946M
Valuation Multiples
Start free trialInnovAge Financials
InnovAge reported last 12-month revenue of $957M and EBITDA of $84M.
In the same LTM period, InnovAge generated $434M in gross profit, $84M in EBITDA, and had net loss of ($3M).
Revenue (LTM)
InnovAge P&L
In the most recent fiscal year, InnovAge reported revenue of $854M and EBITDA of $34M.
InnovAge is unprofitable as of last fiscal year, with gross margin of 18%, EBITDA margin of 4%, and net margin of (4%).
Financial data powered by Morningstar, Inc.
InnovAge Stock Performance
InnovAge has current market cap of $991M, and enterprise value of $946M.
Market Cap Evolution
InnovAge's stock price is $7.30.
InnovAge share price decreased by 3.6% in the last 30 days, and increased by 98.5% in the last year.
InnovAge has an EPS (earnings per share) of $-0.22.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $946M | $991M | -3.6% | -3.6% | -9.0% | 98.5% | $-0.22 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialInnovAge Valuation Multiples
InnovAge trades at 1.0x EV/Revenue multiple, and 11.2x EV/EBITDA.
EV / Revenue (LTM)
InnovAge Financial Valuation Multiples
As of June 2, 2026, InnovAge has market cap of $991M and EV of $946M.
InnovAge has a P/E ratio of (285.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified InnovAge Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


InnovAge Margins & Growth Rates
InnovAge grew revenue by 13% and EBITDA by 157% in the last fiscal year.
In the most recent fiscal year, InnovAge reported gross margin of 18%, EBITDA margin of 4%, and net margin of (4%).
InnovAge Margins
InnovAge Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
InnovAge Operational KPIs
InnovAge's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
InnovAge's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
InnovAge's Rule of X is 34% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
InnovAge Competitors
InnovAge competitors include Omada Health, Ship Healthcare Holdings, Summerset Group Holdings, Enhabit, Ambea, Healthcare Services Group, Ryman Healthcare, Regis Healthcare, Aveanna Healthcare and Oncology Institute.
Most InnovAge public comparables operate across Long-Term Care.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.5x | 3.1x | 138.8x | 80.5x | |||
| 0.2x | 0.2x | 4.1x | 4.2x | |||
| 8.4x | 8.0x | 13.1x | 14.6x | |||
| - | 1.1x | - | 10.6x | |||
| 1.5x | 1.5x | 8.4x | 8.2x | |||
| 0.7x | 0.6x | 11.3x | 10.6x | |||
| 3.2x | 2.8x | (84.5x) | 44.4x | |||
| 3.5x | 3.0x | 16.8x | 30.4x | |||
This data is available for Pro users. Sign up to see all InnovAge competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout InnovAge
| When was InnovAge founded? | InnovAge was founded in 2015. |
| Where is InnovAge headquartered? | InnovAge is headquartered in United States. |
| How many employees does InnovAge have? | As of today, InnovAge has over 2K employees. |
| Who is the CEO of InnovAge? | InnovAge's CEO is Patrick Blair. |
| Is InnovAge publicly listed? | Yes, InnovAge is a public company listed on Nasdaq. |
| What is the stock symbol of InnovAge? | InnovAge trades under INNV ticker. |
| When did InnovAge go public? | InnovAge went public in 2021. |
| Who are competitors of InnovAge? | InnovAge main competitors include Omada Health, Ship Healthcare Holdings, Summerset Group Holdings, Enhabit, Ambea, Healthcare Services Group, Ryman Healthcare, Regis Healthcare, Aveanna Healthcare, Oncology Institute. |
| What is the current market cap of InnovAge? | InnovAge's current market cap is $991M. |
| What is the current revenue of InnovAge? | InnovAge's last 12 months revenue is $957M. |
| What is the current revenue growth of InnovAge? | InnovAge revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of InnovAge? | Current revenue multiple of InnovAge is 1.0x. |
| What is the current EBITDA of InnovAge? | InnovAge's last 12 months EBITDA is $84M. |
| What is InnovAge's EBITDA margin? | InnovAge's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of InnovAge? | Current EBITDA multiple of InnovAge is 11.2x. |
| What is the current FCF of InnovAge? | InnovAge's last 12 months FCF is $20M. |
| What is InnovAge's FCF margin? | InnovAge's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of InnovAge? | Current FCF multiple of InnovAge is 47.4x. |
| How many companies InnovAge has acquired to date? | InnovAge hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies InnovAge has invested to date? | InnovAge hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to InnovAge
Lists including InnovAge
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.